File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The effective transfection of a low dose of negatively charged drug-loaded DNA-nanocarriers into cancer cells via scavenger receptors

TitleThe effective transfection of a low dose of negatively charged drug-loaded DNA-nanocarriers into cancer cells via scavenger receptors
Authors
KeywordsCisplatin (CPT)
DNA-nanowires (DNA-NWs)
HepG2 resistant cancer cells
Scavenger receptors
Issue Date2021
PublisherElsevier: Open Access Journals. The Journal's web site is located at http://www.journals.elsevier.com/journal-of-pharmaceutical-analysis
Citation
Journal of Pharmaceutical Analysis, 2021, v. 11 n. 2, p. 174-182 How to Cite?
AbstractDNA-nanotechnology-based nano-architecture scaffolds based on circular strands were designed in the form of DNA nanowires (DNA-NWs) as a polymer of DNA-triangles. Circularizing a scaffold strand (84-NT) was the critical step followed by annealing with various staple strands to make stiff DNA-triangles. Atomic force microcopy (AFM), and native polyacrylamide gel electrophoresis (PAGE), UV-analysis, MTT-assay, flow cytometry, and confocal imaging were performed to assess the formulated DNA-NWs and cisplatin (CPT) loading. The AFM and confocal microscopy images revealed a uniform shape and size distribution of the DNA-NWs, with lengths ranging from 2 to 4 μm and diameters ranging from 150 to 300 nm. One sharp band at the top of the lane (500 bp level) with the loss of electrophoretic mobility during the PAGE (native) gel analysis revealed the successful fabrication of DNA-NWs. The loading efficiency of CPT ranged from 66.85 to 97.35 %. MTT and flow cytometry results showed biocompatibility of the blank DNA-NWs even at 95 % concentration compared with the CPT-loaded DNA-NWs. The CPT-loaded DNA-NWs exhibited enhanced apoptosis (22%) compared to the apoptosis (7%) induced by the blank DNA-NWs. The release of CPT from the DNA-NWs was sustained at < 75% for 6 h in the presence of serum, demonstrating suitability for systemic applications. The IC50 of CPT@DNA-NWs was reduced to 12.8 nM CPT, as compared with the free CPT solution exhibiting an IC50 of 51.2 nM. Confocal imaging revealed the targetability, surface binding, and slow internalization of the DNA-NWs in the scavenger-receptor-rich cancer (HepG2) cells compared with the control cell line.
Persistent Identifierhttp://hdl.handle.net/10722/294787
ISSN
2023 Impact Factor: 6.1
2023 SCImago Journal Rankings: 1.068
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorBaig, Mirza Muhammad Faran Ashraf-
dc.contributor.authorZhang, Chengfei-
dc.contributor.authorAkhtar, Muhammad Furqan-
dc.contributor.authorSaleem, Ammara-
dc.contributor.authorMudassir, Jahanzeb-
dc.date.accessioned2020-12-10T09:47:54Z-
dc.date.available2020-12-10T09:47:54Z-
dc.date.issued2021-
dc.identifier.citationJournal of Pharmaceutical Analysis, 2021, v. 11 n. 2, p. 174-182-
dc.identifier.issn2095-1779-
dc.identifier.urihttp://hdl.handle.net/10722/294787-
dc.description.abstractDNA-nanotechnology-based nano-architecture scaffolds based on circular strands were designed in the form of DNA nanowires (DNA-NWs) as a polymer of DNA-triangles. Circularizing a scaffold strand (84-NT) was the critical step followed by annealing with various staple strands to make stiff DNA-triangles. Atomic force microcopy (AFM), and native polyacrylamide gel electrophoresis (PAGE), UV-analysis, MTT-assay, flow cytometry, and confocal imaging were performed to assess the formulated DNA-NWs and cisplatin (CPT) loading. The AFM and confocal microscopy images revealed a uniform shape and size distribution of the DNA-NWs, with lengths ranging from 2 to 4 μm and diameters ranging from 150 to 300 nm. One sharp band at the top of the lane (500 bp level) with the loss of electrophoretic mobility during the PAGE (native) gel analysis revealed the successful fabrication of DNA-NWs. The loading efficiency of CPT ranged from 66.85 to 97.35 %. MTT and flow cytometry results showed biocompatibility of the blank DNA-NWs even at 95 % concentration compared with the CPT-loaded DNA-NWs. The CPT-loaded DNA-NWs exhibited enhanced apoptosis (22%) compared to the apoptosis (7%) induced by the blank DNA-NWs. The release of CPT from the DNA-NWs was sustained at < 75% for 6 h in the presence of serum, demonstrating suitability for systemic applications. The IC50 of CPT@DNA-NWs was reduced to 12.8 nM CPT, as compared with the free CPT solution exhibiting an IC50 of 51.2 nM. Confocal imaging revealed the targetability, surface binding, and slow internalization of the DNA-NWs in the scavenger-receptor-rich cancer (HepG2) cells compared with the control cell line.-
dc.languageeng-
dc.publisherElsevier: Open Access Journals. The Journal's web site is located at http://www.journals.elsevier.com/journal-of-pharmaceutical-analysis-
dc.relation.ispartofJournal of Pharmaceutical Analysis-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCisplatin (CPT)-
dc.subjectDNA-nanowires (DNA-NWs)-
dc.subjectHepG2 resistant cancer cells-
dc.subjectScavenger receptors-
dc.titleThe effective transfection of a low dose of negatively charged drug-loaded DNA-nanocarriers into cancer cells via scavenger receptors-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.jpha.2020.10.003-
dc.identifier.scopuseid_2-s2.0-85100183198-
dc.identifier.hkuros320903-
dc.identifier.volume11-
dc.identifier.issue2-
dc.identifier.spage174-
dc.identifier.epage182-
dc.identifier.isiWOS:000647667700004-
dc.identifier.issnl2095-1779-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats